These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

99 related items for PubMed ID: 12498913

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Polyamines in a genetic animal model of paroxysmal dyskinesia.
    Richter A, Morrison LD.
    Brain Res; 2003 Aug 15; 981(1-2):168-73. PubMed ID: 12885438
    [Abstract] [Full Text] [Related]

  • 3. Role of striatal NMDA receptor subunits in a model of paroxysmal dystonia.
    Avchalumov Y, Sander SE, Richter F, Porath K, Hamann M, Bode C, Kirschstein T, Köhling R, Richter A.
    Exp Neurol; 2014 Nov 15; 261():677-84. PubMed ID: 25139804
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Evaluation of the NR2B-selective NMDA receptor antagonist Ro 63-1908 on rodent behaviour: evidence for an involvement of NR2B NMDA receptors in response inhibition.
    Higgins GA, Ballard TM, Huwyler J, Kemp JA, Gill R.
    Neuropharmacology; 2003 Mar 15; 44(3):324-41. PubMed ID: 12604092
    [Abstract] [Full Text] [Related]

  • 6. Antidystonic efficacy of nitric oxide synthase inhibitors in a rodent model of primary paroxysmal dystonia.
    Richter A, Löschmann PA, Löscher W.
    Br J Pharmacol; 2000 Nov 15; 131(5):921-6. PubMed ID: 11053212
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Pharmacological and genetic evidence indicates that combined inhibition of NR2A and NR2B subunit containing NMDA receptors is required to disrupt prepulse inhibition.
    Spooren W, Mombereau C, Maco M, Gill R, Kemp JA, Ozmen L, Nakanishi S, Higgins GA.
    Psychopharmacology (Berl); 2004 Aug 15; 175(1):99-105. PubMed ID: 14985927
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Identification of critical residues in the amino terminal domain of the human NR2B subunit involved in the RO 25-6981 binding pocket.
    Malherbe P, Mutel V, Broger C, Perin-Dureau F, Kemp JA, Neyton J, Paoletti P, Kew JN.
    J Pharmacol Exp Ther; 2003 Dec 15; 307(3):897-905. PubMed ID: 14534359
    [Abstract] [Full Text] [Related]

  • 11. Effects of intrastriatal injections of glutamate receptor antagonists on the severity of paroxysmal dystonia in the dtsz mutant.
    Sander SE, Richter A.
    Eur J Pharmacol; 2007 Jun 01; 563(1-3):102-8. PubMed ID: 17349621
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. NMDA NR2B subtype-selective receptor antagonists fail to antagonize electrically-precipitated seizures and elicit popping in mice.
    Burket JA, Mastropaolo J, Rosse RB, Katz EU, Deutsch SI.
    Eur Neuropsychopharmacol; 2010 Mar 01; 20(3):207-10. PubMed ID: 20022475
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Therapeutic significance of NR2B-containing NMDA receptors and mGluR5 metabotropic glutamate receptors in mediating the synaptotoxic effects of β-amyloid oligomers on long-term potentiation (LTP) in murine hippocampal slices.
    Rammes G, Hasenjäger A, Sroka-Saidi K, Deussing JM, Parsons CG.
    Neuropharmacology; 2011 May 01; 60(6):982-90. PubMed ID: 21310164
    [Abstract] [Full Text] [Related]

  • 18. Effects of N-methyl-D-aspartate receptor antagonism on neuroleptic-induced orofacial dyskinesias.
    Konitsiotis S, Tsironis C, Kiortsis DN, Evangelou A.
    Psychopharmacology (Berl); 2006 Apr 01; 185(3):369-77. PubMed ID: 16518645
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Enhanced attention and impulsive action following NMDA receptor GluN2B-selective antagonist pretreatment.
    Higgins GA, Silenieks LB, MacMillan C, Sevo J, Zeeb FD, Thevarkunnel S.
    Behav Brain Res; 2016 Sep 15; 311():1-14. PubMed ID: 27180168
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.